| Gene amplification and multiple mutations of the K-ras oncogene in Kaposi s sarcoma. | sarcoma, |
| Early mutational activation of the c-Ki-ras oncogene in endometrial carcinoma. | endometrial, |
| K-ras oncogene codon 12 point mutations in testicular cancer. | testicular, |
| Mutations of Ki-ras oncogene codon 12 in betel quid chewing-related human oral squamous cell carcinoma in Taiwan. | oral |
| Thyroid specific expression of the Ki-ras oncogene in transgenic mice. | thyroid, |
| Immunohistochemical detection of ras p21 oncoprotein in breast cancer imprints. | breast, |
| [Quantitative immunohistochemical study of ras oncogene product P21 in laryngeal carcinomas and its clinical importance]. | laryngeal, |
| Expression of ras oncogene p21 protein in normal and neoplastic laryngeal tissues: correlation with histopathological features and epidermal growth factor receptors. | laryngeal, |
| Ki-ras oncogene mutations in tumors and DNA adducts formed by benz[j]aceanthrylene and benzo[a]pyrene in the lungs of strain A/J mice. | lung, |
| K-ras oncogene activation in lung adenocarcinomas from former smokers. Evidence that K-ras mutations are an early and irreversible event in the development of adenocarcinoma of the lung. | lung, |
| Neoplastic transformation of a human prostate epithelial cell line by the v-Ki-ras oncogene. | prostate, |
| Immunolocalization of ras oncogene p21 in human liver diseases. | liver, |
| Comparison of K-ras oncogene activation in pancreatic duct carcinomas and cholangiocarcinomas induced in hamsters by N-nitrosobis(2-hydroxypropyl)amine. | pancreatic,cholangiocarcinoma, |
| Identification of K-ras oncogene mutations in the pure pancreatic juice of patients with ductal pancreatic cancers. | pancreatic, |
| Expression of ras oncogene p21 protein in normal and neoplastic ovarian tissues: correlation with histopathologic features and receptors for estrogen, progesterone, and epidermal growth factor. | ovarian, |
| Position specificity of Ki-ras oncogene mutations during the progression of colorectal carcinoma. | colorectal, |
| Detection of point mutations in the Kirsten-ras oncogene provides evidence for the multicentricity of pancreatic carcinoma. | pancreatic, |
| Activation of the c-Ki-ras oncogene in aflatoxin B1-induced hepatocellular carcinoma and adenoma in the rat: detection by denaturing gradient gel electrophoresis. | liver, |
| Prevalence of G-to-T transversions among K-ras oncogene mutations in human colorectal tumors in Yugoslavia. | colorectal, |
| K-ras oncogene activation in atypical alveolar hyperplasias of the human lung. | lung, |